Policy | January 01, 2026
Govt. issues draft amendment to remove cough syrups from Schedule K
Once finalized, cough syrups will no longer be available for over-the-counter sale
Once finalized, cough syrups will no longer be available for over-the-counter sale
Applications include detailed scientific rationale and supporting clinical evidence
Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
The drug had previously received orphan drug designation for this rare cancer on March 31, 2025
Finerenone is the first therapy targeting the mineralocorticoid receptor pathway to demonstrate cardiovascular benefits in heart failure patients
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
The anatomage table is one of the most advanced 3D real-tissue–based anatomy visualization systems in the world
Panacea Biotec receives acceptance from CMSS for supply of bOPV
Medico Remedies receives order worth US$ 1,781,000
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Subscribe To Our Newsletter & Stay Updated
